Online Courses (English)
This just in:

State PCS

Daily Updates

Science & Technology

Effect of BCG Vaccine on Covid-19

  • 03 Apr 2020
  • 3 min read

Why in News

Recently, Doctors and scientists in India have expressed caution on a study, which argues that countries that have deployed the BCG-tuberculosis vaccine in their immunisation programmes have seen fewer deaths from COVID-19.

Key Points Related to Study

  • BCG Vaccine Policy and COVID-19 Deaths
    • The middle and high-income countries
      • Countries that have universal BCG policy had 0.78 deaths per million people.
      • The countries that never had a universal BCG policy had a larger mortality rate, with 16.39 deaths per million people, a significant variation.
    • Low and middle-income countries, even if they had universal immunisation policies, were excluded from the analysis because they were also likely to have low testing rates for COVID-19 infection and therefore fewer reported deaths.
    • India having a universal BCG policy in place and relatively fewer deaths as a proportion of confirmed coronavirus infections, wasn’t included in the analysis.
  • BCG Vaccine confers a strong immune response
    • The BCG vaccine is known to confer a strong immune response and a significant degree of protection against leprosy and non-invasive bladder cancers.
    • Those countries where the elderly were likely to have had a BCG shot in their childhood were likely to be better protected against coronavirus because COVID-19 was particularly lethal to the elderly.
  • Cases of Different Countries
    • Japan (which has a BCG policy since 1947) had one of the early cases of COVID-19 but it has maintained a low mortality rate despite not implementing the most strict forms of social isolation.
      • Japan had 1,655 cases and 65 deaths as of March 29.
    • Iran, which has seen at least 3,000 deaths,began implementing its BCG vaccination policy only in 1984 and therefore anyone over 36 was vulnerable.
    • Spain, France, the United States, Italy and the Netherlands:
      • These countries don’t have universal BCG policies and have seen many deaths from COVID-19.
      • Many of these countries don’t have a universal programme because BCG has been shown to not be always protective against tuberculosis in adults as well as an increased risk of mycobacterium (bacteria) species.
      • Italy, where the COVID-19 mortality is very high, never implemented universal BCG vaccination.
  • Views of Indian Scientists and Doctors
    • it is premature for India, that has had a consistent TB vaccination policy since 1968, to take comfort from the study.
    • Australia, the Netherlands, the United States are going to vaccinate healthcare workers with BCG. This may provide some evidence.

Source: TH

SMS Alerts
 

Please login or register to view note list

close

Please login or register to list article as bookmarked

close
 

Please login or register to make your note

close

Please login or register to list article as progressed

close

Please login or register to list article as bookmarked

close